Advertisement
Home Tags Prescription Drugs

Tag: Prescription Drugs

For patients with juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy

Tocilizumab Useful for Uveitis in Juvenile Idiopathic Arthritis

0
Rapid, maintained improvement in ocular parameters for JIA-linked uveitis refractory to anti-TNF tx
Evolocumab and inclisiran

ACC: Meds Targeting PCSK9 Show Benefit for High-Risk Patients

0
Evolocumab and inclisiran inhibit proprotein convertase subtilisin-kexin type 9
For patients in septic shock

Thiamine May Reduce Progression to Renal Replacement Therapy

0
Findings for patients in septic shock
For food-allergic adolescents at risk for anaphylaxis

Supervised Self-Injection Ups Teens’ Comfort With Approach

0
Findings show improved comfort with self-injection, reduced anxiety for food-allergic adolescents
From 2001 to 2013

Concurrent Benzodiazepine, Opioid Use Up Significantly

0
Providers urged to exercise caution in prescribing opioids for patients already using benzodiazepines
For patients with laryngopharyngeal reflux

Rx Improves Nasal Symptoms in Laryngopharyngeal Reflux

0
Decrease in median total nasal resistance score and Nasal Obstruction Symptom Evaluation Score
The American Diabetes Association (ADA) recommends metformin as first-line therapy for type 2 diabetes

ADA Updates Standards of Medical Care in Diabetes

0
Metformin should be initiated at the time of T2DM diagnosis unless there are contraindications
For patients with chronic hepatitis C treated with direct-acting antivirals

HBV Reactivation Seen With DAA Treatment of Chronic Hep C

0
HBV virological reactivation in four of seven patients with current HBV infection; none with past infection
For patients with type 2 diabetes

Better Outcomes in T2DM With No Delay in Tx Intensification

0
Greater reduction in HbA1c, but increased risk of severe hypoglycemia with no delay in intensification
For patients with type 2 diabetes

Vildagliptin, Metformin Have Different Effects on BP in T2DM

0
Vildagliptin lowers BP, elevates HR, while metformin increases HR with no impact on BP